{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:39:01Z","timestamp":1792795141335,"version":"4.5.0"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Behavioural Brain Research"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.bbr.2015.05.052","type":"journal-article","created":{"date-parts":[[2015,6,5]],"date-time":"2015-06-05T15:37:54Z","timestamp":1433518674000},"page":"306-314","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":141,"special_numbering":"C","title":["Beneficial effects of sodium butyrate in 6-OHDA induced neurotoxicity and behavioral abnormalities: Modulation of histone deacetylase activity"],"prefix":"10.1016","volume":"291","author":[{"given":"Sorabh","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajeev","family":"Taliyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumel","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbr.2015.05.052_bib0005","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.neuroscience.2014.12.008","article-title":"Vinpocetine attenuates MPTP-induced motor deficit and biochemical abnormalities in Wistar rats","volume":"286","author":"Sharma","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbr.2015.05.052_bib0010","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.pharmthera.2013.05.010","article-title":"Epigenetic targeting of histone deacetylase: therapeutic potential in Parkinson\u2019s disease?","volume":"140","author":"Harrison","year":"2013","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bbr.2015.05.052_bib0015","doi-asserted-by":"crossref","first-page":"6537","DOI":"10.1093\/emboj\/cdg615","article-title":"Critical loss of CBP\/p300 histone acetylase activity by caspase-6 during neurodegeneration","volume":"22","author":"Rouaux","year":"2003","journal-title":"EMBO J."},{"key":"10.1016\/j.bbr.2015.05.052_bib0020","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2174\/156720506778249407","article-title":"Histone deacetylase inhibitors: a novel therapeutic approach to Huntington\u2019s disease (complex mechanism of neuronal death)","volume":"3","author":"Sadri-Vakili","year":"2006","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.bbr.2015.05.052_bib0025","doi-asserted-by":"crossref","first-page":"5280","DOI":"10.1093\/hmg\/dds379","article-title":"Selective histone deacetylase (HDAC) inhibition imparts beneficial effects in Huntington\u2019s disease mice: implications for the ubiquitin-proteasomal and autophagy systems","volume":"21","author":"Jia","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbr.2015.05.052_bib0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2011\/143269","article-title":"Targeting HDAC a promising therapy for Alzheimer\u2019s disease","volume":"2011","author":"Xu","year":"2011","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.bbr.2015.05.052_bib0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12031-014-0461-x","article-title":"Histone deacetylase inhibitor, trichostatin A, improves learning and memory in high-fat diet-induced cognitive deficits in mice","volume":"56","author":"Sharma","year":"2015","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.bbr.2015.05.052_bib0040","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s00210-014-1081-2","article-title":"Synergistic effects of GSK-3\u03b2 and HDAC inhibitors in intracerebroventricular streptozotocin-induced cognitive deficits in rats","volume":"388","author":"Sharma","year":"2015","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.bbr.2015.05.052_bib0045","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s002800050922","article-title":"Plasma pharmacokinetics of butyrate after intravenous administration of sodium butyrate or oral administration of tributyrin or sodium butyrate to mice and rats","volume":"43","author":"Egorin","year":"1999","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.bbr.2015.05.052_bib0050","doi-asserted-by":"crossref","first-page":"9418","DOI":"10.1523\/JNEUROSCI.23-28-09418.2003","article-title":"Histone deacetylase inhibition by sodium butyrate chemotherapy ameliorates the neurodegenerative phenotype in Huntington\u2019s disease mice","volume":"23","author":"Ferrante","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbr.2015.05.052_bib0055","doi-asserted-by":"crossref","first-page":"4281","DOI":"10.1073\/pnas.0737363100","article-title":"Histone deacetylase inhibitors prevent oxidative neuronal death independent of expanded polyglutamine repeats via an Sp1-dependent pathway","volume":"100","author":"Ryu","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbr.2015.05.052_bib0060","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1093\/hmg\/ddm078","article-title":"Histones associated with downregulated genes are hypo-acetylated in Huntington\u2019s disease models","volume":"16","author":"Sadri-Vakili","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbr.2015.05.052_bib0065","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.brainres.2010.07.041","article-title":"Protection of dopaminergic cells from MPP+-mediated toxicity by histone deacetylase inhibition","volume":"1354","author":"Kidd","year":"2010","journal-title":"Brain Res."},{"key":"10.1016\/j.bbr.2015.05.052_bib0070","doi-asserted-by":"crossref","first-page":"3012","DOI":"10.1093\/hmg\/ddl243","article-title":"Alpha-synuclein acts in the nucleus to inhibit histone acetylation and promote neurotoxicity","volume":"15","author":"Kontopoulos","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbr.2015.05.052_bib0075","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1017\/S1461145708009024","article-title":"Histone deacetylase inhibitors up-regulate astrocyte GDNF and BDNF gene transcription and protect dopaminergic neurons","volume":"11","author":"Wu","year":"2008","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.bbr.2015.05.052_bib0080","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1006\/exnr.1998.6848","article-title":"Characterization of behavioral and neurodegenerative changes following partial lesions of the nigrostriatal dopamine system induced by intrastriatal 6-hydroxydopamine in the rat","volume":"152","author":"Kirik","year":"1998","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.bbr.2015.05.052_bib0085","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.bbr.2004.10.010","article-title":"Comparison of 6-hydroxydopamineinduced medial forebrain bundle and nigrostriatal terminal lesions in a lateralised nose-poking task in rats","volume":"159","author":"Dowd","year":"2005","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.bbr.2015.05.052_bib0090","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"1986"},{"key":"10.1016\/j.bbr.2015.05.052_bib0095","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3892\/etm.2014.1726","article-title":"Anti-inflammatory effect of sodium butyrate preconditioning during myocardial ischemia\/reperfusion","volume":"8","author":"Hu","year":"2014","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.bbr.2015.05.052_bib0100","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1038\/npp.2009.125","article-title":"Selective boosting of transcriptional and behavioral responses to drugs of abuse by histone deacetylase inhibition","volume":"34","author":"Sanchis-Segura","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbr.2015.05.052_bib0105","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jneumeth.2010.03.026","article-title":"A rotarod test for evaluation of motor skill learning","volume":"189","author":"Shiotsuki","year":"2010","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.bbr.2015.05.052_bib0110","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/0003-9861(59)90090-6","article-title":"Tissue sulfhydryl groups","volume":"82","author":"Ellman","year":"1959","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.bbr.2015.05.052_bib0115","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1042\/bj0990667","article-title":"Mechanism of lipid peroxide formation in animal","volume":"99","author":"Wills","year":"1996","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbr.2015.05.052_bib0120","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0003-2697(82)90118-X","article-title":"Analysis of nitrate, nitrite and [15N] nitrate in biological fluids","volume":"126","author":"Green","year":"1982","journal-title":"Ann. Biochem. Exp. Med."},{"key":"10.1016\/j.bbr.2015.05.052_bib0125","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the Folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbr.2015.05.052_bib0130","first-page":"303294","article-title":"Targeting histone deacetylases: a novel approach in Parkinson\u2019s disease","volume":"2015","author":"Sharma","year":"2015","journal-title":"Parkinsons Dis."},{"key":"10.1016\/j.bbr.2015.05.052_bib0135","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.bbr.2014.01.051","article-title":"Caffeine neuroprotective effects on 6-OHDA-lesioned rats are mediated by several factors, including pro-inflammatory cytokines and histone deacetylase inhibitions","volume":"264","author":"Machado-Filho","year":"2014","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.bbr.2015.05.052_bib0140","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1097\/WNR.0b013e328308b355","article-title":"Enhancement of glutamate uptake in 1-methyl-4-phenylpyridinium-treated astrocytes by trichostatin A","volume":"19","author":"Wu","year":"2008","journal-title":"Neuroreport"},{"key":"10.1016\/j.bbr.2015.05.052_bib0145","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1017\/S1461145708009024","article-title":"Histone deacetylase inhibitors up-regulate astrocyte GDNF and BDNF gene transcription and protect dopaminergic neurons","volume":"11","author":"Wu","year":"2008","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.bbr.2015.05.052_bib0150","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.neuroscience.2013.04.037","article-title":"Sodium butyrate improves locomotor impairment and early mortality in a rotenone-induced Drosophila model of Parkinson\u2019s disease","volume":"246","author":"St Laurent","year":"2013","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbr.2015.05.052_bib0155","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1126\/science.7901908","article-title":"Oxidative stress, glutamate, and neurodegenerative disorders","volume":"262","author":"Coyle","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.bbr.2015.05.052_bib0160","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1016\/j.freeradbiomed.2008.03.009","article-title":"6-Hydroxydopamine (6-OHDA) induces Drp1-dependent mitochondrial fragmentation in SH-SY5Y cells","volume":"44","author":"Gomez-Lazaro","year":"2008","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bbr.2015.05.052_bib0165","doi-asserted-by":"crossref","first-page":"a009332","DOI":"10.1101\/cshperspect.a009332","article-title":"Mitochondrial biology and Parkinson\u2019s disease","volume":"2","author":"Perier","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.bbr.2015.05.052_bib0170","doi-asserted-by":"crossref","first-page":"15466","DOI":"10.1016\/S0021-9258(17)36277-4","article-title":"Hydroxyl radical attack on dopamine","volume":"60","author":"Slivka","year":"1985","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbr.2015.05.052_bib0175","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1046\/j.1471-4159.1995.64020919.x","article-title":"Enzymatic oxidation of dopamine: the role of prostaglandin H synthase","volume":"64","author":"Hastings","year":"1995","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbr.2015.05.052_bib0180","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/BF02896785","article-title":"Protective effect of GSH on PD model induced by 6-OHDA in vitro","volume":"22","author":"Xu","year":"2002","journal-title":"J. Huazhong Univ. Sci. Technol. Med. Sci."},{"key":"10.1016\/j.bbr.2015.05.052_bib0185","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.neuint.2013.02.001","article-title":"Effects of sodium butyrate on oxidative stress and behavioral changes induced by administration of D-AMPH","volume":"62","author":"Steckert","year":"2013","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.bbr.2015.05.052_bib0190","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1523\/JNEUROSCI.3200-07.2008","article-title":"Pulse inhibition of histone deacetylases induces complete resistance to oxidative death in cortical neurons without toxicity and reveals a role for cytoplasmic p21(waf1\/cip1) in cell cycleindependent neuroprotection","volume":"28","author":"Langley","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbr.2015.05.052_bib0195","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1523\/JNEUROSCI.5467-07.2008","article-title":"Synergistic neuroprotective effects of lithium and valproic acid or other histone deacetylases inhibitors in neurons: roles of glycogen synthase kinase-3 inhibition","volume":"28","author":"Leng","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbr.2015.05.052_bib0200","first-page":"113","article-title":"Biochemistry of postmortem brains in Parkinson\u2019s disease: historical overview and future prospects","volume":"Suppl. 72","author":"Nagatsu","year":"2007","journal-title":"J. Neural Trans."},{"key":"10.1016\/j.bbr.2015.05.052_bib0205","doi-asserted-by":"crossref","first-page":"e38113","DOI":"10.1371\/journal.pone.0038113","article-title":"Sodium phenylbutyrate controls neuroinflammatory and antioxidant activities and protects dopaminergic neurons in mouse models of Parkinson\u2019s disease","volume":"7","author":"Roy","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.bbr.2015.05.052_bib0210","doi-asserted-by":"crossref","first-page":"100e6","DOI":"10.1007\/s002130100871","article-title":"Chronic lithium treatment increases the expression of brain-derived neurotrophic factor in the rat brain","volume":"158","author":"Fukumoto","year":"2001","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bbr.2015.05.052_bib0215","doi-asserted-by":"crossref","first-page":"51e9","DOI":"10.1038\/sj.mp.4002099","article-title":"The mood stabilizers lithium and valproate selectively activate the promoter IV of brain-derived neurotrophic factor in neurons","volume":"14","author":"Yasuda","year":"2009","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.bbr.2015.05.052_bib0220","doi-asserted-by":"crossref","first-page":"e33453","DOI":"10.1371\/journal.pone.0033453","article-title":"Genes are often sheltered from the global histone hyperacetylation induced by HDAC inhibitors","volume":"7","author":"Halsall","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.bbr.2015.05.052_bib0225","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1006\/exnr.2000.7483","article-title":"Reduced BDNF mRNA expression in the Parkinson\u2019s disease substantia nigra","volume":"166","author":"Howells","year":"2000","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.bbr.2015.05.052_bib0230","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0304-3940(99)00463-2","article-title":"Brain-derived growth factor and nerve growth factor concentrations are decreased in the substantia nigra in Parkinson\u2019s disease","volume":"270","author":"Mogi","year":"1999","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bbr.2015.05.052_bib0235","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/00001756-199401120-00014","article-title":"6-Hydroxydopamine lesions reduce BDNF mRNA levels in adult rat brain substantia nigra","volume":"5","author":"Venero","year":"1994","journal-title":"Neuroreport"},{"key":"10.1016\/j.bbr.2015.05.052_bib0240","doi-asserted-by":"crossref","first-page":"e0117698","DOI":"10.1371\/journal.pone.0117698","article-title":"Alterations of BDNF and trkB mRNA expression in the 6-hydroxydopamine-induced model of preclinical stages of Parkinson\u2019s disease: an influence of chronic pramipexole in rats","volume":"10","author":"Berghauzen-Maciejewska","year":"2015","journal-title":"Plos One"},{"key":"10.1016\/j.bbr.2015.05.052_bib0245","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.brainresbull.2014.09.006","article-title":"Physical training prevents depressive symptoms and a decrease in brain-derived neurotrophic factor in Parkinson\u2019s disease","volume":"108","author":"Tuon","year":"2014","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.bbr.2015.05.052_bib0250","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.brainresrev.2004.05.002","article-title":"Functional interactions between somatodendritic dopamine release, glutamate receptors and brain-derived neurotrophic factor expression in mesencephalic structures of the brain","volume":"47","author":"Bustos","year":"2004","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.bbr.2015.05.052_bib0255","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S0169-328X(00)00095-4","article-title":"Transient increase of brain derived neurotrophic factor mRNA expression in substantia nigra reticulata after partial lesion of the nigrostriatal dopaminergic pathway","volume":"79","author":"Aliaga","year":"2000","journal-title":"Mol. Brain Res."},{"key":"10.1016\/j.bbr.2015.05.052_bib0260","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1002\/jnr.22063","article-title":"NMDA receptors mediate an early up-regulation of brain-derived neurotrophic factor expression in substantia nigra in a rat model of presymptomatic Parkinson\u2019s disease","volume":"87","author":"Bustos","year":"2009","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.bbr.2015.05.052_bib0265","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1017\/S1461145708009024","article-title":"Histone deacetylase inhibitors up-regulate astrocyte GDNF and BDNF gene transcription and protect dopaminergic neurons","volume":"11","author":"Wu","year":"2008","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.bbr.2015.05.052_bib0270","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/j.1476-5381.2011.01575.x","article-title":"Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, protects dopaminergic neurons from neurotoxin-induced damage","volume":"165","author":"Chen","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bbr.2015.05.052_bib0275","first-page":"1","article-title":"Valproic acid neuroprotection in 6-OHDA lesioned rat, a model for Parkinson\u2019s disease","author":"Monti","year":"2012","journal-title":"HOAJ Biol."}],"container-title":["Behavioural Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432815300218?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432815300218?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,5,11]],"date-time":"2022-05-11T13:11:40Z","timestamp":1652274700000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166432815300218"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":55,"alternative-id":["S0166432815300218"],"URL":"https:\/\/doi.org\/10.1016\/j.bbr.2015.05.052","relation":{},"ISSN":["0166-4328"],"issn-type":[{"value":"0166-4328","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Beneficial effects of sodium butyrate in 6-OHDA induced neurotoxicity and behavioral abnormalities: Modulation of histone deacetylase activity","name":"articletitle","label":"Article Title"},{"value":"Behavioural Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbr.2015.05.052","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}